The Changing Role of European Pharma

There are a small number of cannabis pharmaceutical companies who lead large swathes of the medical cannabis market. Has this corner of the industry already become a monopoly? Where do businesses see genuine room for growth in the next 3-5 years? Are there innovations on the horizon which might see a rejuvenated interest from the big pharmaceutical players?

We host a series of three intimate, 10 minute, 1-1 interviews with leading industry executives and innovators to check in on the health of medical cannabis in Europe, with a forward looking focus on the next big opportunities.